Despite the broadly described role of Annexin A2 as a poor-prognosis marker during cancer progression, it has recently been reported to be induced for degradation by other oncogenic E3 ubiquitin-ligases, such as TRIM65 [38,39]. Here, TRIM65 is linked to cancer.